Razpipadon
Atypical antipsychotic medication
| Razpipadon | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | Atypical antipsychotic |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Razpipadon is an atypical antipsychotic medication primarily used in the treatment of schizophrenia and bipolar disorder. It is known for its efficacy in managing both positive and negative symptoms of schizophrenia, as well as its mood-stabilizing properties in bipolar disorder.
Pharmacology[edit | edit source]
Razpipadon functions as a dopamine receptor antagonist, particularly targeting the D2 receptors in the brain. It also exhibits antagonistic activity at serotonin receptors, including the 5-HT2A receptor, which contributes to its atypical profile. This dual action is believed to reduce the risk of extrapyramidal symptoms commonly associated with typical antipsychotics.
Mechanism of Action[edit | edit source]
The mechanism of action of Razpipadon involves the modulation of neurotransmitter pathways in the brain. By blocking dopamine receptors, it helps to alleviate symptoms such as hallucinations and delusions. The serotonin receptor antagonism is thought to improve mood and cognitive function, addressing the negative symptoms of schizophrenia.
Clinical Use[edit | edit source]
Razpipadon is prescribed for the management of schizophrenia and bipolar disorder. It is effective in reducing the frequency and severity of psychotic episodes and stabilizing mood swings. The medication is typically administered orally, with dosage adjustments based on the patient's response and tolerance.
Side Effects[edit | edit source]
Common side effects of Razpipadon include weight gain, sedation, and metabolic changes. Patients may also experience dizziness, dry mouth, and gastrointestinal disturbances. Long-term use requires monitoring for potential metabolic syndrome and other health concerns.
Development and Approval[edit | edit source]
Razpipadon was developed as part of a new generation of antipsychotic medications aimed at improving the safety and tolerability profile compared to older drugs. It received approval from regulatory agencies after demonstrating efficacy in clinical trials.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
